書籍情報から探す
青年期急性増悪期統合失調症の抗精神病薬による治療歴のない集団と治療歴のある集団別のプラセボ対照のlurasidone短期投与の有効性と安全性【二次出版】
Christoph U. Correll1,2,3, Michael Tocco4,5, Jay Hsu4,5, Robert Goldman4,5, Andrei Pikalov4,5
1Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, 2Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, 3Department of Child and Adolescent Psychiatry, Charite Universitatsmedizin, 4Global Medical Affairs, Sunovion Pharmaceuticals Inc., Fort Lee, 5Sunovion Pharmaceuticals Inc., Marlborough
臨床精神薬理 28 (2) 199-214, 2025.
1Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, 2Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, 3Department of Child and Adolescent Psychiatry, Charite Universitatsmedizin, 4Global Medical Affairs, Sunovion Pharmaceuticals Inc., Fort Lee, 5Sunovion Pharmaceuticals Inc., Marlborough
臨床精神薬理 28 (2) 199-214, 2025.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,793円(税込) です。
青年期統合失調症患者の抗精神病薬による治療歴のない集団と治療歴のある集団別のlurasidone非盲検長期投与の安全性と有効性 : post-hoc解析【二次出版】
Christoph U. Correll(a),(b),(c), Michael Tocco(d), Andrei Pikalov(d), Jay Hsu(d), Robert Goldman(d)
(a)Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, (b)Hofstra Northwell School of Medicine, Department of Psychiatry and Molecular Medicine, (c)Charite Universitatsmedizin, Department of Child and Adolescent Psychiatry, (d)Sunovion Pharmaceuticals Inc
臨床精神薬理 28 (2) 215-232, 2025.
(a)Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, (b)Hofstra Northwell School of Medicine, Department of Psychiatry and Molecular Medicine, (c)Charite Universitatsmedizin, Department of Child and Adolescent Psychiatry, (d)Sunovion Pharmaceuticals Inc
臨床精神薬理 28 (2) 215-232, 2025.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,793円(税込) です。



